The present invention provides compositions including anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7, and their use in treating cancer.
GOODPASTURE ANTIGEN BINDING PROTEIN DETECTION AND INHIBITION AND ITS USE IN DIABETES
申请人:Fibrostatin, Sociedad Limitada
公开号:EP3049815B1
公开(公告)日:2019-03-13
Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes
申请人:FibroStatin, S.L.
公开号:US20150093378A1
公开(公告)日:2015-04-02
Disclosed herein are methods for treating type 2 diabetes, limiting development of type 2 diabetes, and treating a pre-diabetic state by administering to a subject in need thereof a GPBP inhibitor. Also disclosed herein are methods for diagnosing a pre-diabetic state and for diagnosing a propensity to develop type 2 diabetes by determining an amount of GPBP in a sample from a subject and comparing to control.